ASP Isotopes Inc. (NASDAQ:ASPI) anticipates an earnings per share (EPS) of -$0.065 and revenue of approximately$6.1 million for the upcoming quarter.The company's strategic acquisition of Renergen could potentially reduce enrichment costs by 96%, aiming to boost EBITDA by 2030.ASPI's financial health shows a strong liquidity position with a current ratio of 14.72, despite a significant reliance on debt financing, indicated by a debt-to-equity ratio of 4.03.ASP Isotopes Inc. (NASDAQ:ASPI) is a company that ...